Infos pratiques & communications

Antimicrobial resistance (AMR) poses a significant global threat of far-reaching proportions. It is estimated that drugresistant infections contribute to nearly 5 million deaths every year. Unless we act now, common diseases will become untreatable and modern life-saving ...

ESGCD will be hosting a websymposium on Wednesday, 30 March 2022 at 17:00 CEST. Programme:Chairs: Dr. Kerrie Davies, Prof. Fidelma FitzpatrickTyping using RBT/MLVA – Dr. Marcella KrutovaWGS as typing method – Dr. Sandra JanezicIPC using typing – ...

Applicants are required to demonstrate that ISAC funds will be utilised for a clearly defined piece of research, which will have an identifiable outcome on completion of the work. At least one country involved must be a low- to middle- income country. Researc ...

Description Antimicrobial resistance caused 4.95 million deaths associated with AMR and 1.27 million deaths attributable to AMR in 2019. Vaccines can prevent a proportion of the AMR burden by preventing drug-sensitive and drug-resistant infections, reducing anti ...

The Global Antimicrobial Stewardship Hub is dedicated to the education and training needs of the global infection healthcare community through multi-stakeholder engagement across all health economies.  Dedicated to changing the PAC ...

Webinar Description Join CIDRAP-ASP for a webinar discussing the importance of effective, data-driven infection prevention strategies (IPC) a ...

Context-specific and cost-effective interventions are critical if we are to prevent the spread of infectious organisms and prolong the usefulness of the drugs that tackle them. This includes concerted efforts to prevent infection in the first place as well as optimise the way we use antimicrobials in clinical and veterinary ...

JPIAMR in partnership with the Medical Research Council (MRC UKRI) are hosting a workshop on antibiotic resistance, specifically looking for input from Early to Mid-Career Researchers. Antibiotic resistance is prevalent in bacterial infections across the world, threatenin ...

CARB-X continues its acceleration of innovative therapeutics, preventatives and diagnostics against antibiotic-resistant bacteria (BOSTON: May 19, 2022) – After celebrating its five-year anniversary in 2021, ...

Press release published on